Biomira, a biotechnology company, has announced the appointment of Gary Christianson to the newly created position of chief operating officer at the company.
Christianson will be leading the manufacturing and process scale-up activities associated with Biomira's Phase III vaccine Stimuvax (L-BLP25), as well as a number of other technical development and manufacturing activities associated with the company's small molecule pipeline.
He will also play a key role in integrating the firm's multi-site activities in an effort to improve efficiency and productivity at the company.
Christianson previously held positions at GlaxoSmithKline's Biologics Unit, Corixa and RIBI ImmunoChem Research.
Isolagen, an aesthetic and therapeutic company, has appointed Declan Daly as chief operating officer.
While still retaining his position as the company's chief financial officer, Daly will oversee manufacturing operations, clinical and regulatory affairs and quality systems.
Isolagen chief executive and chairman Nicholas Teti said: "I am extremely pleased to promote Declan to chief operating officer. I have worked with him for many years and know that he has the skills, experience and commitment needed to drive the growth and success of Isolagen."
July 18 2007
Bookmark with:
- Digg
- Reddit
- Del.icio.us
- Facebook
- Newsvine
Sign Up to Exec UK now for FREE!